Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Metric	BNTXBiontech SE	INCYIncyte	MRNAModerna
Snapshot
Price	$92.25	$117.71	$59.47
Market cap	$24.67B	$23.35B	$31.65B
Valuation
P/E	—	16.5x	—
Forward P/E	—	11.8x	—
Growth
Revenue growth	-11.8%	21.5%	-30.0%
EPS growth	—	2455.3%	—
Profitability
Net margin	-34.0%	26.7%	-143.6%
ROE	-6.7%	29.2%	-36.7%
Balance sheet & cash
Debt / equity	0.01x	0.01x	0.07x
Free cash flow yield	13.6%	2.2%	-13.6%
Dividend yield	—	—	—
Verdict
Investment rating	Weak· 31	Strong· 86	Weak· 17

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

Year	BNTXtoday $92	INCYtoday $118	MRNAtoday $59
2027	$70.57 – $103.50+12% CAGR	$2,255.89 – $3,308.64+2711% CAGR	$45.49 – $66.73+12% CAGR
2028	$71.98 – $105.57+7% CAGR	$57,645.02 – $84,546.03+2580% CAGR	$46.40 – $68.06+7% CAGR
2029	$73.42 – $107.69+5% CAGR	$1,473,009.02 – $2,160,413.23+2538% CAGR	$47.33 – $69.42+5% CAGR
2030	$74.89 – $109.84+4% CAGR	$37,639,946.83 – $55,205,255.35+2517% CAGR	$48.28 – $70.81+4% CAGR
2031	$76.39 – $112.04+4% CAGR	$961,817,325.28 – $1,410,665,410.42+2504% CAGR	$49.24 – $72.23+4% CAGR
5-yr CAGR	-3.7% – 4.0%	2312.4% – 2504.5%	-3.7% – 4.0%